☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CHMP Positive Opinion
UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures
October 23, 2020
Janssen's Tremfya (guselkumab) Receives CHMP's Positive Opinion for Approval to Treat Active Psoriatic Arthritis (PsA)
October 19, 2020
Takeda's Vedolizumab SC Receives CHMP's Positive Opinion as a Maintenance Therapy for Moderately to Severely Active UC or CD
February 28, 2020
Mundipharma's Pegfilgrastim Mundipharma (biosimilar- pegfilgrastim) Receives CHMP Positive Opinion for MAA in EU
October 18, 2019
Celltrion's CT-P13 (biosimilar- infliximab) Receives CHMP's Positive Opinion for its SC Formulation to Treat Rheumatoid Arthritis
September 23, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.